Does adjuvant intracameral triamcinolone acetonide increase the effectiveness of phacotrabeculectomy? A case-control study

Basit Öğe Kaydı
dc.contributor.authorAslan, Fatih
dc.contributor.authorÖktem, Çağlar
dc.date.accessioned2021-02-19T21:20:47Z
dc.date.available2021-02-19T21:20:47Z
dc.date.issued2020
dc.departmentALKÜ
dc.description.abstractAims: To investigate the effect of intracameral triamcinolone acetonide (TA) on surgical success in 5-fluorouracil (5-FU) supported primary phacotrabeculectomy (PT) cases. Material and Methods: This retrospective study included 23 eyes (study group) of 23 patients who underwent TA during PT and 26 eyes (control group) of 26 patients without TA. PT patients in the study group received 1 mg TA intraoperatively at the end of surgery. Pre-and postoperative visual acuity, intraocular pressure (IOP), and number of antiglaucoma drugs used were compared. Postoperative complications and need for 5-FU injection were evaluated for both groups. Results: Mean age was 64.1 2 ± 1.91 (48–86) years in the control group and 66.52 ± 2.02 (52–86) years in the study group (p = 0.824). Comparison of pre-and postoperative IOP values showed significant decreases in postoperative IOP levels at all-time points in both the control and study groups (p < 0.001). The only significant difference between groups was on postoperative first day (study group: 9.22 ± 1.41 mmHg; control group: 6.35 ± 2.17 mmHg, p < 0.001). Need for postoperative 5-FU injection was significantly more common in the control group (p = 0.023). Conclusion: Intracameral injection of 1 mg TA at the end of PT surgery did not yield superior results in postoperative IOP compared to PT alone, and the two groups showed similar IOP reduction. When given as an adjunct to PT, 1 mg TA suppresses anterior segment inflammation and reduces the need for 5-FU injection. © 2020, Czech Medical Association J.E. Purkyne. All rights reserved.
dc.identifier.doi10.31348/2020/14
dc.identifier.endpage76en_US
dc.identifier.issn1211-9059
dc.identifier.issue2en_US
dc.identifier.pmid33126801
dc.identifier.scopusqualityQ4
dc.identifier.startpage68en_US
dc.identifier.urihttps://doi.org/10.31348/2020/14
dc.identifier.urihttps://hdl.handle.net/20.500.12868/682
dc.identifier.volume76en_US
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthor0-belirlenecek
dc.language.isoen
dc.publisherCzech Medical Association J.E. Purkyne
dc.relation.ispartofCeska a Slovenska Oftalmologie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject5-Fluorouracil
dc.subjectPhacotrabeculectomy
dc.subjectTrabeculectomy
dc.subjectTriamcinolone acetonide
dc.titleDoes adjuvant intracameral triamcinolone acetonide increase the effectiveness of phacotrabeculectomy? A case-control study
dc.title.alternativeZvyšuje intrakamerální aplikace triamcinolon acetonidu ú?innost fakotrabekulektomie? P?ípadová kontrolní studie
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu